Duopharma Biotech Berhad Cash Flow Statement

Financials in millions MYR. Fiscal year is January - December.

Millions MYR. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Net Income	87.46	62.65	52.65	70.11	65.68
Depreciation & Amortization	45.62	40.58	38.76	33.48	29.66
Other Amortization	-	4.81	4.29	2.72	2.29
Loss (Gain) From Sale of Assets	-0.01	-0.39	-	-	0.01
Asset Writedown & Restructuring Costs	9.39	0.02	2.43	-	0.1
Provision & Write-off of Bad Debts	0.84	-1.43	4.1	-0.49	0.1
Other Operating Activities	20.98	11.44	-7.11	22.74	7.29
Change in Accounts Receivable	-29.44	-46.6	-5.81	-13.28	-4.14
Change in Inventory	-60.67	-15.35	-12.39	-53.36	-78.43
Change in Accounts Payable	32.67	27.62	-28.1	8.35	20.64
Operating Cash Flow	106.84	83.34	48.8	70.27	43.2
Operating Cash Flow Growth	28.19%	70.77%	-30.54%	62.63%	-39.45%
Capital Expenditures	-26.76	-23.57	-32.95	-65.18	-109.36
Sale of Property, Plant & Equipment	0.01	0.5	-	-	0.02
Sale (Purchase) of Intangibles	-6.24	-10.32	-6.61	-5.84	-5.64
Investment in Securities	-	-	-6.42	-	-2.07
Other Investing Activities	5.87	5.97	2.75	1.52	1.2
Investing Cash Flow	-27.12	-27.43	-43.23	-69.5	-115.86
Long-Term Debt Issued	58.15	93.37	486.35	85.67	186.78
Long-Term Debt Repaid	-78.74	-128.87	-369.97	-59.27	-89.46
Net Debt Issued (Repaid)	-20.59	-35.5	116.37	26.4	97.33
Common Dividends Paid	-33.67	-26.93	-8.85	-8.2	-44.96
Financing Cash Flow	-54.26	-62.43	107.52	18.2	52.37
Foreign Exchange Rate Adjustments	0.87	0.56	-0.23	0.69	0.24
Net Cash Flow	26.33	-5.96	112.87	19.66	-20.05
Free Cash Flow	80.08	59.77	15.86	5.08	-66.16
Free Cash Flow Growth	33.99%	276.91%	211.98%	-	-
Free Cash Flow Margin	8.60%	7.35%	2.25%	0.73%	-10.35%
Free Cash Flow Per Share	0.08	0.06	0.02	0.01	-0.07
Cash Interest Paid	24.52	27.02	21.71	16.54	11.97
Cash Income Tax Paid	17.42	10.66	16.83	24.51	11.66
Levered Free Cash Flow	51.19	31.95	-10.33	-6.71	-60.93
Unlevered Free Cash Flow	66.66	48.05	0.72	-1.02	-56.91
Change in Working Capital	-57.44	-34.32	-46.3	-58.29	-61.93

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.